Search by Drug Name or NDC

NDC 43063-0901-01 Lithium Carbonate 450 mg/1 Details

Lithium Carbonate 450 mg/1

Lithium Carbonate is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is LITHIUM CARBONATE.

MedlinePlus Drug Summary

Lithium is used to treat and prevent episodes of mania (frenzied, abnormally excited mood) in people with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Lithium is in a class of medications called antimanic agents. It works by decreasing abnormal activity in the brain.

Related Packages: 43063-0901-01
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Lithium

Product Information

NDC	43063-0901
Product ID	43063-901_05bb2f42-e5c4-6c1d-e063-6394a90aa81b
Associated GPIs	59500010100410
GCN Sequence Number	004005
GCN Sequence Number Description	lithium carbonate TABLET ER 450 MG ORAL
HIC3	H2M
HIC3 Description	BIPOLAR DISORDER DRUGS
GCN	15730
HICL Sequence Number	001669
HICL Sequence Number Description	LITHIUM CARBONATE
Brand/Generic	Generic
Proprietary Name	Lithium Carbonate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Lithium Carbonate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	450
Active Ingredient Units	mg/1
Substance Name	LITHIUM CARBONATE
Labeler Name	PD-Rx Pharmaceuticals, Inc.
Pharmaceutical Class	Mood Stabilizer [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA076691
Listing Certified Through	2024-12-31

Package

NDC 43063-0901-01 (43063090101)

Pricing Information	N/A
NDC Package Code	43063-901-01
Billing NDC	43063090101
Package	100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-901-01)
Marketing Start Date	2018-09-25
NDC Exclude Flag	N